This dosage sensitivity suggests the ATXN2 gene as a good candidate for detailed analysis of genetic variation, both common and rare, in a number of human phenotypes as diverse as obesity, motor hyperactivity, anxiety, and depression. Here, ATXN2 is linked to depressive disorder.